Routes of Administration, Pharmacokinetics and Safety of Medicinal Cannabis-Reference-Cited by-同舟云学术

Routes of Administration, Pharmacokinetics and Safety of Medicinal Cannabis

Published:2021 Issue: Volume: Page:513-557
ISSN:
Container-title:Medicinal Cannabis and CBD in Mental Healthcare
language:
Short-container-title:

Author:

O’Brien Kylie,Blair Philip

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-78559-8_11

Reference158 articles.

1. Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4:1770–804.

2. World Health Organization (WHO). World Health Organization Expert Committee on Drug Dependence Pre-Review. Cannabis Plant and Cannabis Resin. Geneva: World Health Organization, 2018a. Available at: https://www.who.int/medicines/access/controlled-substances/ecdd_40_meeting/en/. Accessed 20 Jan 2021.

3. Lintzeris N, Davis J, Elias N, et al. Medicinal cannabis in Australia 2016: the Cannabis as medicine survey (CAMS-16). Med J Aust. 2018;209(5):211–6.

4. Sexton M, Cuttler C, Finnell J, Mischley L. A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy. Cannabis Cannabinoid Res. 2016;1:131–8.

5. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Internal Med. 2018;49:12–9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive update on cannabidiol, its formulations and drug delivery systems;Phytochemistry Reviews;2024-08-09

2. A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance;Journal of Psychopharmacology;2024-02-08

3. Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective;Expert Review of Clinical Pharmacology;2023-11